News/announcements

 

Purchase of own shares

The Company announces that on 24 April 2018 it purchased 16,398 of its ordinary shares on the London Stock Exchange at a price of 300 pence per share.  The purchased shares will be cancelled.

Read more

Purchase of own shares

In line with the Company’s announcement on 7 March 2018, the Company would consider returning further cash to shareholders by way of share buybacks during the course of 2018 in lieu of paying a dividend

Read more

Results of the 2018 AGM

The following proxy votes were received for the Resolutions:

Read more

Results of 2018 Annual General Meeting

 

The Board announces that the Annual General Meeting of the Company was held this morning. 

Read more

AGM Statement Trading update

At today’s Annual General Meeting of the Company, the following trading update is being given by the Chairman, Ian Johnson.

Read more

Annual Financial Report

Following the preliminary announcement issued on 7 March 2018, the full electronic version of the BIOQUELL annual report is now available to download in PDF format on the Company’s website at www.bioquellplc.com. The Notice of Annual General Meeting and the Form of Proxy are also available for download.

Read more

AGM Notice of Meeting

The Annual General Meeting of Bioquell PLC will take place on Monday 23 April 2018 at the office of Harwood Capital LLP, 6 Stratton Street, London, W1J 8LD. The Meeting will start at 11am. The Formal Notice of the AGM and the form of Proxy are available to download - please follow the link below.

Read more

Holding in Company

Liontrust notification of increase in share capital.

Read more

Bioquell PLC – 2017 Preliminary Results

Bioquell PLC (LSE symbol:BQE), the specialist provider of biodecontamination systems and services to the international Life Sciences, Pharmaceutical and Healthcare markets, today announces its preliminary results for the year ending 31st December 2017

Read more

Trading statement

Bioquell PLC ("Bioquell") (LSE symbol: BQE) – a leading provider of specialist biodecontamination products and services for the international Life Sciences, pharmaceutical and healthcare markets today announces an update on its trading performance prior to entering the closed period ahead of the preliminary results for the year to 31 December 2017.

Read more